AbbVie Inc.
ABBV 232.36 (0.40%) 0.92
Health Care
Biotechnology
Quality Checklist 1/8
Est. EPS Growth > 5%
5Y Shares Out Change < 0%
ROIC > 10%
Debt/Equity < 1
Current Ratio > 1
Quick Ratio > 1
Net Margin > 10%
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $410.67(B)
EV: $473.89(B)
Total Equity: $-2.60(B)
Earnings date: Jan-30-2026
P/E: 174.71
Forward P/E: 21.84
P/FCF: 20.86
P/S: 6.89
P/B: N/A
EPS: $1.3
EPS (fwd): $10.6
FCF/share: $11.1
Revenue/share: $33.7
Book value/share: $-1.5
ROIC: 3.3%
ROA: 1.7%
ROE: 140.9%
Debt/Equity: 48
Current Ratio: 0.70
Gross margin: 71.5%
Operating margin: 24.1%
Net margin: 4.0%
Dividend/share: $6.6
Div. yield: 2.82%
Growth Estimates
Revenue
CAGR: 7.1%FY+1$60.92(B)
FY+2(+9.4%)$66.61(B)
FY+3(+7.6%)$71.65(B)
FY+4(+7.0%)$76.68(B)
FY+5(+4.6%)$80.19(B)
Net Income
CAGR: 14.5%FY+1$18.92(B)
FY+2(+32.7%)$25.11(B)
FY+3(+11.3%)$27.96(B)
FY+4(+9.5%)$30.61(B)
FY+5(+6.2%)$32.52(B)
EPS
CAGR: 15.4%FY+1$10.64
FY+2(+33.9%)$14.25
FY+3(+11.1%)$15.83
FY+4(+10.9%)$17.55
FY+5(+7.4%)$18.85
FCF per share
CAGR: 13.6%FY+1$11.13
FY+2(+33.3%)$14.83
FY+3(+7.9%)$16.00
FY+4(+7.6%)$17.22
FY+5(+7.7%)$18.54